Edgewise Therapeutics
John Moore has extensive legal experience in the biotechnology sector, currently serving as General Counsel at Edgewise Therapeutics since September 2020. Previously, John held the position of General Counsel and Secretary at Peloton Therapeutics and operated as Principal at John R Moore, LLC, providing consulting and legal services to early-stage biotech companies. John spent over 15 years at Array BioPharma Inc. as Vice President, General Counsel, and Secretary, and held board membership at Nivalis Therapeutics. Early legal career experience includes roles at Wilson Sonsini Goodrich & Rosati, Arnold White & Durkee, and Kenyon & Kenyon LLP. Academic credentials include a Doctor of Law from the University of North Carolina School of Law, a Master of Science in Biochemistry from the University of Illinois Urbana-Champaign, and a Bachelor of Science in Chemistry from the University of North Carolina at Chapel Hill.
This person is not in any teams
This person is not in any offices
Edgewise Therapeutics
1 followers
Edgewise Therapeutics is a biotechnology company harnessing proven expertise and understanding of skeletal muscle physiology to develop novel, transformative therapies for serious muscle diseases. Based in Boulder, Colorado, we have built a state-of-the-art muscle research facility to capitalize on new insights into the nature and consequences of muscle adaptation and injury with disease. Edgewise recently closed it’s Series B financing round which will support the advancement of Edgewise Therapeutic’s lead product candidate into clinical development for Duchenne and Becker Muscular Dystrophy (DMD and BMD) as well as expansion of the company’s pipeline. The company’s leadership team has founded multiple biotechnology startups, several of which have gone on to become publicly-traded companies and brings to bear a depth of experience in drug discovery, development and commercialization.